Neurology
Annals of Medicine
In the Neurology section of Annals of Medicine we consider for publication the latest advances in:
| Alzheimer's Disease | Amyotrophic Lateral Sclerosis (ALS) | Cerebrovascular Disease |
| Dementia | Demyelinating Disease | Epilepsy |
| Headache | Movement Disorders | Multiple Sclerosis (MS) |
| Neuromuscular Disorders | Pediatric Neurology | Peripheral Neuropathy |
In addition, this section considers research and reviews on neurological diseases including pathophysiology, prevention, diagnosis and management, epidemiology and multi-disciplinary care.
Annals of Medicine
Q1 Rank
Two-Year Impact Factor 3.243
Five-Year Impact Factor 3.840
MEDLINE® Indexed
CiteScore 5.70
Meet the Section Editor
Angela Genge, MD, FRCP (c)
Dr. Angela Genge has been the Director of the Clinical Research Unit at the Montreal Neurological Institute since 2004. Her expertise and ground-breaking work in the introduction of innovative therapies in the rare disease space has led her to be a sought after member of numerous advisory boards for companies developing therapies for these diseases. Clinically, she is the Director of the Neuro ALS clinical program and multidisciplinary clinic, and a neuromuscular neurologist. Throughout her career she has received numerous awards, most recently the 2018 Forbes Norris Award, the DIVA of Distinction Award, and the Governor General Diamond Jubilee Award.
Why is Annals of Medicine the Best Publication for Your Research?
Fully open access, general medical journal publishing articles under a CC BY license, allowing maximum sharing and reuse of articles to our international readership;
Publishing all scientifically valid research, including reporting of negative and null data, from translational to clinical research in all disciplines and therapy areas;
Led by an international editorial team of subject experts who ensure a constructive and rigorous peer review process;
Your research is promoted via a tailored, multi-channel approach to maximize visibility, readership and impact.
